Welcome to our dedicated page for Kaival Brnds Innovatns Grp SEC filings (Ticker: KAVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating FDA rulings, patent details, and flavor-ban risks inside Kaival Brands’ SEC documents can feel like navigating a maze. Each 300-page annual report details electronic nicotine delivery regulations, while sudden 8-K updates disclose marketing-order news that can move the stock overnight. Stock Titan’s AI turns that complexity into clarity, giving you the exact paragraph you need in seconds.
Whether you need the Kaival Brands quarterly earnings report 10-Q filing to track BIDI Stick sell-through, or want Kaival Brands insider trading Form 4 transactions as soon as CEO Niraj Patel trades, our platform delivers every form as it hits EDGAR—no refresh required. AI-powered summaries highlight revenue by distribution channel, litigation reserves, and cash-burn trends so you can focus on decisions, not document hunts.
Here’s how professionals use this page:
- Kaival Brands Form 4 insider transactions real-time alerts for pre-earnings activity
- Kaival Brands annual report 10-K simplified to review FDA compliance sections
- Kaival Brands proxy statement executive compensation to assess incentive alignment
- Kaival Brands 8-K material events explained for rapid reaction to regulatory shifts
- Kaival Brands earnings report filing analysis to compare flavor mix margins quarter over quarter
Start understanding Kaival Brands SEC documents with AI today. Every filing is archived, searchable, and paired with expert context so you never miss a Kaival Brands executive stock transactions Form 4 or critical disclosure. Complex ENDS regulations are finally readable.
Kaival Brands Innovations Group, Inc. (KAVL) reported results of its 2025 annual stockholders meeting. As of the October 3, 2025 record date, 11,593,402 common shares were outstanding. A quorum was reached with 7,576,844 shares represented, equal to 65.35% of outstanding voting shares.
All director nominees were elected to serve until the 2026 annual meeting or until their successors are elected and qualified. Reported votes included: David Worner (5,515,833 for), Mark Thoenes (5,566,366 for), Ashesh Modi (5,538,862 for), and Ketankumar Patel (5,535,589 for). Directors are elected by a plurality of votes cast.
One proposal requiring a majority of outstanding shares was approved with 7,554,497 votes for, 22,094 against, and 253 abstentions.
Kaival Brands Innovations Group, Inc. is asking shareholders to elect four directors to serve until the 2026 Annual Meeting and to ratify the Board's selection of MaloneBailey, LLP as the independent auditor for the fiscal year ending
The meeting is virtual at www.virtualshareholdermeeting.com/KAVL2025, accessible with a 16-digit control number. The filing discloses recent board turnover: multiple resignations earlier in 2024 and appointments on
Kaival Brands Innovations Group, Inc. (KAVL) filed a 10-Q for the quarter ended July 31, 2025 that highlights material legal, regulatory and liquidity risks. The company discloses substantial reliance on royalty revenue from a PMI licensing agreement and concentration of product sales: $1,228,535 from QuikTrip, $990,589 (19%) from GPM and $575,183 (11%) from FAVS. Management reports an accumulated deficit (presented as approximately $6.62 million) and intangible assets of $11.80 million with amortization expense of $589,806 for the nine months. The filing warns of significant doubt about the company’s ability to continue as a going concern due to the need for additional financing and regulatory uncertainty, including an FDA marketing denial order for Classic BIDI Stick upheld by the 11th Circuit and an ITC patent infringement investigation. Cash on hand included uninsured deposits of $1,018,926. The company paid $405,000 in Series B dividends on December 3, 2024 and recognized $2,873,750 of stock compensation expense in the nine months ended July 31, 2025.